Thalassemias: Overview of Pathophysiology and Treatment

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

K. Fertrin

Impact and Risks of Chronic Anemia in Thalassemia Patients

Farrukh Shah

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Indy Hematology Review

A. Tefferi

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Indy Hematology Review

A. Tefferi

Thalassemia: Overview of Pathophysiology and Risk for Malignancies

Ali Taher

Myeloid Malignancies: Hot Topics in 2024

Yale Cancer Center

N. Podoltsev

2024 Updates on Myeloproliferative Neoplasms, PV, and ET

Integrity CE

A. Tefferi

Laboratory Evaluation and Diagnosis of Thalassemia

Norafiza Mohd Yasin

Principles of Iron Management in Thalassemia

Nita Radhakrishnan

Managing Benign Hematology Disorders

Indy Hematology Review

C. Kessler

Case-Based Discussion: Managing Non-Transfusion-Dependent Thalassemia

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

A. Taher

2024 Updates in PV/ET

University of Colorado Division of Hematology

B. McMahon

PV and Its Relationship to Acute Leukemia

16th International Congress on Myeloproliferative Neoplasms

J. Spivak

What to Do When Patch Testing is Negative?

American Contact Dermatitis Society (ACDS)

M. Montanez-Wiscovich

Current Management of Accelerated/Blast-Phase MPNs

UChicago Medicine

A. Patel

Diagnosis of Thalassemia: Molecular, Lab-Based, and Iron-Based Testi…

Sean Campbell

Treatment of Thalassemia From Transplant to Novel Agents

Nita Radhakrishnan

Mitapivat for Thalassemia: Results From the Ph3 ENERGIZE-T Study

Stefan Eber

Optimal Life-Long Management and Curative Therapies for Transfusion-…

Robert Klaassen